CommercialPrior AuthLow impact
Edarbi (azilsartan)
Blue Cross & Blue Shield of Mississippi·MS · Family Medicine, Internal Medicine, Cardiology +2 more·Medical Policy
Effective date
Mar 15, 2025
We identified it
Jun 20, 2026
Summary
BCBS Mississippi updated their prior authorization policy for Edarbi (azilsartan) with new medication failure and intolerance definitions. The policy now clarifies that drug samples cannot be used to satisfy therapy requirements, and updates dose requirement criteria for approval.
Action Required
Before March 15, 2025: Billing team must update prior authorization documentation requirements for Edarbi prescriptions. Ensure providers understand that drug samples cannot be documented as current therapy for PA requests. Update PA forms to reflect new medication failure (3+ months at appropriate doses) and intolerance (4+ weeks with documented interventions) definitions. Verify dose requirements match FDA labeling before submission.